INDEX / DIRECTORY / GLOBUS MEDICAL / DIGITAL

Globus Medical DIGITAL

DIGITAL INFRASTRUCTURE AUDIT UPDATED 2026-10-21
Digital Score 0.00 /10 E Globus Medical - Complicity Index 181
Digital 0.00

Evidence-only forensic audit. Scoring happens downstream - see the main dossier for the composite assessment.

Forensic audits like this are reader-funded - no sponsors, no ads. Support OpenIntel →

Research date: 21 October 2026.

Globus Medical, Inc. is the in-scope U.S. issuer: a Delaware corporation headquartered at 2560 General Armistead Avenue, Audubon, Pennsylvania, whose business is musculoskeletal medical technology and healthcare solutions.1, 2 The audit distinguishes its ordinary healthcare operations from any state, military, surveillance or occupied-territory use.

Enterprise Technology Stack & Vendor Relationships

Globus Medical’s October 2026 privacy notice names Google Analytics and Hotjar as website-analytics services and states that service providers may perform functions including data storage, order fulfilment, financial, legal and marketing services.3 Its information-security page describes a global information-security program but does not identify specific security vendors.4

The worker surfaced a cybersecurity-incident statement, but the cited investor page could not be independently retrieved. The incident details and any alleged geographic attribution remain unresolved in this audit.

No public evidence identified in the bounded research pass for a verified Globus licensing, subscription or integration relationship with Check Point, Wiz, SentinelOne, CyberArk, NICE, Verint, Claroty, Palo Alto Networks or another Israeli-origin enterprise-technology vendor. No public evidence identified for an integrator deploying Israeli-origin technology into Globus infrastructure. The current corporate privacy/security materials retrieved do not name such a relationship.3, 4

Surveillance, Biometrics & Retail Technology

ExcelsiusGPS is described by Globus as a robotic navigation platform for spine and cranial procedures that combines a rigid robotic arm with navigation, uses CT/fluoroscopy/MR-compatible workflows, and provides real-time trajectory guidance and visualization of instruments and patient anatomy.5 ExcelsiusHub is described as a freehand surgical-navigation system with patient-array monitoring, imaging registration and connectivity to other Excelsius surgical systems.6 Globus’ current Excelsius technology page groups these systems with imaging, extended-reality and orthopedic robotic products for surgical care.7

No public evidence identified that Globus uses or provides Israeli-origin facial recognition, biometric identification, predictive policing, sentiment analysis, social-media monitoring or workforce-surveillance technology. No public evidence identified that such tools reach Globus through a managed-service or bundled-platform provider. The verified computer-vision/navigation functions retrieved are clinical surgical-navigation functions, not public-space or identity surveillance.5, 6, 7

Cloud Infrastructure, Data Residency & Sovereign Cloud Participation

The October 2026 privacy notice says personal information may be transferred to Globus affiliates, service providers or systems in other countries, including the United States, and identifies service providers for data storage and other business functions.3 The retrieved notice does not identify Israel as a hosting, processing or routing location, and it does not name an Israel-based cloud provider.3

No public evidence identified for a Globus-owned, leased or colocated data centre in Israel; participation in Project Nimbus or another Israeli government cloud program; or a Globus service marketed for Israeli state data sovereignty, residency or infrastructure resilience. The current public contact page retrieved provides international contact routing and lists selected company locations, but the returned text did not identify an Israel office.8

Defence, Intelligence & Security Sector Technology Relationships

Historical corporate records establish an Israeli commercial presence, but the retrieved evidence does not establish military procurement. SEC subsidiary exhibits named “Globus Medical Israel Ltd” in 2012 and “Globus Medical Israel Limited” in 2014, 2018 and 2021.9, 10, 11, 12 The 2012, 2014 and 2018 records are [pre-2020]. The worker also surfaced a registry-mirror status lead, but its page could not be independently retrieved; the alleged company number and dissolution dates remain unresolved.

The worker surfaced a possible Sheba Medical Center lead through the inaccessible registry mirror. Without a retrievable source or primary procurement record, the lead remains unresolved and does not establish paid procurement, a current state contract, a military customer or IDF/Ministry of Defense deployment.

No public evidence identified for a verified Globus contract with the Israeli Ministry of Defense, IDF, intelligence agencies or security bodies; for deployment of Globus commercial technology for military/intelligence surveillance; or for development, sale or maintenance of offensive cyber or digital-weapons capabilities. The latest annual filing describes Globus as a healthcare technology company serving hospitals, ambulatory surgery centres and physicians, and its current significant-subsidiary list does not identify an Israel entity.1, 13 Because no verified state/military or settlement technology provision was found, the research could not establish continuation of such provision after 19 July 2024 or after November 2024.

AI, Algorithmic & Autonomous Systems

Globus’ verified advanced digital systems in this research are medical enabling technologies. ExcelsiusGPS performs surgical trajectory alignment/navigation and ExcelsiusHub performs freehand navigation and imaging registration in operating-room workflows.5, 6 The broader Excelsius portfolio includes robotic, imaging and extended-reality systems intended for surgery.7

No public evidence identified that Globus provided AI/ML, computer vision or autonomous decision-support systems to Israeli state, military or security bodies; trained models on civilian, intercepted-communications or surveillance-derived datasets from Israel or occupied territories; or supplied autonomous target-generation, threat-detection or weapons-tracking systems. Nothing retrieved tied the clinical navigation products to kinetic targeting or weapons effects.5, 6, 7

Technology Ecosystem & R&D Footprint

SEC exhibits document the Israeli subsidiary from 2012 through 2021.9, 10, 11, 12 Its current legal status remains unresolved. Globus’s 2025 significant-subsidiary exhibit lists NuVasive, LLC and Nevro, LLC but no Israel entity; the exhibit expressly says it omits subsidiaries that are not significant in the aggregate, so omission alone cannot prove that no Israeli legal entity exists.13

NuVasive became a wholly owned Globus subsidiary through the merger completed on 1 September 2023.14 Nevro became a wholly owned Globus subsidiary on 3 April 2025.15 Nevro’s final standalone subsidiary exhibit listed Switzerland, the United Kingdom, Australia, Germany, Costa Rica and the United States, with no Israel entity shown.16 No primary evidence identified a current NuVasive or Nevro Israeli R&D centre, engineering office or controlled Israeli technology company.

Daniel T. Lemaitre, a Globus director since 2011, served as executive chairman of Israel-based BlueWind Medical from September 2018 to January 2020 [pre-2020] and as its CEO from January 2020 to September 2024.17, 18 This establishes a board member’s prior executive connection to an Israeli medical-device company; no public evidence identified that Globus acquired, invested in, procured from or controlled BlueWind Medical.17, 18

No public evidence identified for a significant Globus patent-licensing or co-development arrangement with Technion, Hebrew University, Weizmann Institute or another Israeli research institution.

Civil Society Scrutiny & Regulatory History

Focused searches against OHCHR, Who Profits, AFSC Investigate, the A/HRC/59/23 title, Don’t Buy Into Occupation and related terms did not surface a target-specific document within the fixed search budget. This bounded result does not establish that no relevant material exists.

No public evidence identified for an organised boycott/divestment campaign specifically based on Globus technology provision, or for an export-control, sanctions, regulatory or legal action involving Globus technology sales to Israeli state entities. The current corporate filings and governance materials retrieved describe the medical-device business, acquisitions and governance but do not identify such a matter.1, 2, 18

Unresolved lead: The unverified cybersecurity-incident lead is not used to establish an Israel nexus.

Footnotes

  1. U.S. SEC, Globus Medical, Inc., Form 10-K for year ended 31 December 2025 - https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm ↩ ↩2 ↩3

  2. U.S. SEC, Globus Medical, Inc., Form 10-Q for quarter ended 30 June 2026 - https://www.sec.gov/Archives/edgar/data/1237831/000162828026054450/gmed-20260630.htm ↩ ↩2

  3. Globus Medical, Privacy Notice, updated 5 October 2026 - https://www.globusmedical.com/privacy-policy/ ↩ ↩2 ↩3 ↩4

  4. Globus Medical, Information Security - https://www.globusmedical.com/about/information-security/ ↩ ↩2

  5. Globus Medical, ExcelsiusGPS Robotic Navigation Platform - https://www.globusmedical.com/musculoskeletal-solutions/excelsiustechnology/excelsiusgps/ ↩ ↩2 ↩3 ↩4

  6. Globus Medical, ExcelsiusHub Freehand Navigation System - https://www.globusmedical.com/musculoskeletal-solutions/excelsiustechnology/excelsiushub/ ↩ ↩2 ↩3 ↩4

  7. Globus Medical, Excelsius Technology portfolio - https://www.globusmedical.com/musculoskeletal-solutions/excelsiustechnology/ ↩ ↩2 ↩3 ↩4

  8. Globus Medical, Contact Us / Other Locations - https://www.globusmedical.com/about/contact/ ↩

  9. U.S. SEC, Globus Medical, Inc., Exhibit 21.1, subsidiaries (2012 filing) - https://www.sec.gov/Archives/edgar/data/1237831/000119312512331390/d319036dex211.htm ↩ ↩2

  10. U.S. SEC, Globus Medical, Inc., Exhibit 21.1, subsidiaries as of 31 December 2014 - https://www.sec.gov/Archives/edgar/data/1237831/000123783115000009/gmed123114ex211.htm ↩ ↩2

  11. U.S. SEC, Globus Medical, Inc., Exhibit 21.1, subsidiaries as of 31 December 2018 - https://www.sec.gov/Archives/edgar/data/1237831/000123783119000014/gmed123118ex211entities.htm ↩ ↩2

  12. U.S. SEC, Globus Medical, Inc., Exhibit 21.1, subsidiaries as of 31 December 2021 - https://www.sec.gov/Archives/edgar/data/1237831/000156276222000037/gmed-20211231xex21_1.htm ↩ ↩2

  13. U.S. SEC, Globus Medical, Inc., Exhibit 21.1, subsidiaries as of 31 December 2025 - https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231xexx211.htm ↩ ↩2

  14. U.S. SEC, Globus Medical, Inc., Form 10-K for year ended 31 December 2024, NuVasive merger disclosure - https://www.sec.gov/Archives/edgar/data/1237831/000156276225000026/gmed-20241231x10k.htm ↩

  15. U.S. SEC, Globus Medical, Inc., Form 8-K, completion of Nevro acquisition, 3 April 2025 - https://www.sec.gov/Archives/edgar/data/1237831/000119312525071923/d931031d8k.htm ↩

  16. U.S. SEC, Nevro Corp., Exhibit 21.1, list of subsidiaries - https://www.sec.gov/Archives/edgar/data/1444380/000144438025000024/nvroex21_1.htm ↩

  17. Globus Medical, Board of Directors, Daniel T. Lemaitre biography - https://www.globusmedical.com/about/board-of-directors/ ↩ ↩2

  18. Globus Medical, 2026 Definitive Proxy Statement - https://www.sec.gov/Archives/edgar/data/1237831/000162828026027196/gmed-20260424.htm ↩ ↩2 ↩3